Research Topics
| Vito AgostiSummaryAffiliation: Columbia University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Predictors of alcohol dependence relapse during recurrence of major depressionVito Agosti
Depression Evaluation Service, New York State Psychiatric Institute, New York, New York 10032, USA
J Addict Dis 32:79-84. 2013..Early onset alcohol dependence and past year drug use disorder significantly increased the likelihood of relapse. Early onset substance use dependence is a more powerful predictor of alcohol relapse than early onset major depression...
Do manualized psychosocial interventions help reduce relapse among alcohol-dependent adults treated with naltrexone or placebo? A meta-analysisVito Agosti
Depression Evaluation Service, New York State Psychiatric Institute, New York, New York 10032, USA
Am J Addict 21:501-7. 2012..These outcomes have spurred researchers to investigate whether the addition of manualized psychosocial therapies with demonstrated efficacy to pharmacotherpy would have a synergistic effect...
Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts?Vito Agosti
New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
J Affect Disord 133:595-9. 2011..To determine if Attention Deficit Hyperactivity Disorder (ADHD) is a risk factor for suicide attempts...
Does personality disorder decrease the likelihood of remission in early-onset chronic depression?Vito Agosti
Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA
Compr Psychiatry 50:491-5. 2009..Elevated rates of PD have been noted in early-onset and chronic forms subtypes of depression. However, scant data exist regarding the link between PD and outcome for this depression subtype...
Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults?Vito Agosti
New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
Soc Psychiatry Psychiatr Epidemiol 44:120-4. 2009..This article tests the hypothesis that remission from substance use disorders is associated with smoking cessation in nicotine dependent young adults...
Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sampleVito Agosti
New York State Psychiatric Institute, 1051 Riverside Drive, 10965, New York, NY, United States
J Affect Disord 108:177-82. 2008..To compare rates of comorbidity, treatment utilization, the course of illness, and past year social functioning of Hypomania with and without Dysphoria Hypomania (mixed state)...
Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depressionVito Agosti
New York State Psychiatric Institute and Columbia College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, USA
Int Clin Psychopharmacol 22:309-11. 2007..No patient developed manic symptoms that required medication discontinuation or mood stabilizer augmentation. Antidepressant monotherapy was found to be a safe and effective treatment for bipolar-II depression...
Predictors of cannabis dependence recovery among epidemiological survey respondents in the United StatesVito Agosti
New York State Psychiatric Institute, New York, New York 10032, USA
Am J Drug Alcohol Abuse 33:81-8. 2007..Recovery was defined as the absence of Cannabis Dependence and Cannabis Abuse during the past year. Logistic Regression analysis revealed that older age, marriage, and non-daily cannabis use were positively associated with recovery...
The effects of alcohol and drug dependence on the course of depressionVito Agosti
Substance Use Research Center, New York State Psychiatric Institute, New York, New York 10032, USA
Am J Addict 15:71-5. 2006..This study analyzed data from the National Comorbidity Survey (NCS). Among respondents with lifetime SUD and unipolar depression, current SUD increased the risk (OR = 2.9) of past year depression and anxiety disorders (OR = 2.2)...
Atypical and non-atypical subtypes of depression: comparison of social functioning, symptoms, course of illness, co-morbidity and demographic featuresV Agosti
New York State Psychiatric Institute and the Department of Psychiatry, Columbia University College of Physicians and Surgeons, NY 10032, USA
J Affect Disord 65:75-9. 2001..There are scant data regarding the demographic and psychosocial characteristics of outpatients with Atypical Depression (AD)...
Predictors of treatment contact among individuals with cannabis dependenceVito Agosti
New York State Psychiatric Institute, 1051 Riverside Drive Box 51, New York, NY 10032, USA
Am J Drug Alcohol Abuse 30:121-7. 2004....
Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependenceVito Agosti
New York State Psychiatric Institute, Substance Abuse Treatment Center, 1051 Riverside Drive, New York, NY 10032, USA
Am J Drug Alcohol Abuse 28:643-52. 2002..The failure to identify comorbidity may lead to inadequate treatment, and a poorer prognosis...
Somatization as a predictor of medication discontinuation due to adverse eventsV Agosti
New York State Psychiatric Institute, New York 10032, USA
Int Clin Psychopharmacol 17:311-4. 2002....
Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depressionVito Agosti
New York State Psychiatric Institute, Unit 35, 1051 Riverside Drive, New York, NY 10032, USA
J Affect Disord 71:113-20. 2002..Studies have confirmed the efficacy of a several antidepressants in the treatment of atypical depression. Whether their pathological dimensions of personality diminish after benefitting from effective medication treatment is unclear...
One year clinical and psychosocial outcomes of early-onset chronic depressionV Agosti
New York State Psychiatric Institute, and the Department of Psychiatry, Columbia University, New York City 10032, USA
J Affect Disord 54:171-5. 1999..However, scant data exists regarding the long-term outcome of these patients treated for this disorder...
Predictors of persistent social impairment among recovered depressed outpatientsV Agosti
New York State Psychiatric Institute and the Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York 10032, USA
J Affect Disord 55:215-9. 1999..The purpose of this study was to identify predictors of residual social impairment among patients who recovered from depression...
Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC studyDavid J Hellerstein
New York State Psychiatric Institute, New York, NY, USA
J Affect Disord 127:84-8. 2010..We hypothesized that individuals with chronic low-grade depression, dysthymic disorder, would have more impaired functioning than individuals with acute major depression or the general population...
One-year follow-up study of suicide attempters treated for drug dependenceVito Agosti
New York State Psychiatric Institute, Depression Evaluation Service, New York, New York 10032, USA
Am J Addict 15:293-6. 2006....
Outcome of cognitive-behavioral therapy for depression: relation to hemispheric dominance for verbal processingG E Bruder
Department of Biopsychology, New York State Psychiatric Institute, New York 10032, USA
J Abnorm Psychol 106:138-44. 1997..The findings suggest that greater left-hemisphere advantage for verbal processing is associated with more favorable outcome of cognitive therapy for depression...
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin
New York State Psychiatric Institute, Division of Substance Abuse, New York, NY, USA Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA
Addiction 108:1084-94. 2013..To evaluate whether venlafaxine-extended release (VEN-XR) is an effective treatment for cannabis dependence with concurrent depressive disorders...
